Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient

E. Eryuksel, B. Yildizeli, C. Cimsit, S. Olgun Tandogdu, S. Karakut (Istanbul, Turkey)

Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session: Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session type: Thematic Poster Session
Number: 2600
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Eryuksel, B. Yildizeli, C. Cimsit, S. Olgun Tandogdu, S. Karakut (Istanbul, Turkey). Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient. Eur Respir J 2013; 42: Suppl. 57, 2600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Pulmonary hypertension in COPD: results from the ASPIRE registry
Source: Eur Respir J 2013; 41: 1292-1301
Year: 2013



Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Regional ventilatory defects in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006


Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Structural brain changes in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014


Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Source: Eur Respir J 2010; 35: 105-111
Year: 2010



Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease?
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014


Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Mechanisms of ECG changes in chronic obstructive pulmonary disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Pulmonary hypertension in patients with COPD
Source: Eur Respir Mon 2012; 57: 138-147
Year: 2012